sumatriptan (Q416978)

sumatriptan (English)

3 October 2016

chemical formula

C₁₄H₂₁N₃O₂S

1 reference

sumatriptan (English)

19 November 2016

canonical SMILES

CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C

1 reference

sumatriptan (English)

19 November 2016

defined daily dose

50 milligram

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N02CC01

6 milligram

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N02CC01

25 milligram

rectal route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N02CC01

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

sumatriptan (English)

1 reference

sumatriptan (English)

medical condition treated

3 October 2016

migraine

1 reference

Drug Indications Extracted from FAERS

2 October 2018

26 August 1997

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/8R78F6L9VO

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020080s049lbl.pdf

migraine without aura

start time

26 August 1997

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/8R78F6L9VO

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020080s049lbl.pdf

giant cell arteritis

start time

26 August 1997

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/8R78F6L9VO

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020080s049lbl.pdf

significant drug interaction

isocarboxazid

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

ergotamine

vasoconstriction

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

5-hydroxytryptamine receptor 1A

1 reference

5-hydroxytryptamine receptor 1B

17 August 2016

1 reference

5-hydroxytryptamine receptor 1D

17 August 2016

1 reference

5-hydroxytryptamine receptor 1E

17 August 2016

1 reference

5-hydroxytryptamine receptor 1F

17 August 2016

1 reference

5-hydroxytryptamine receptor 5A

17 August 2016

1 reference

5-hydroxytryptamine (serotonin) receptor 5A

17 August 2016

1 reference

5-hydroxytryptamine receptor 6

17 August 2016

1 reference

5-hydroxytryptamine receptor 7

17 August 2016

1 reference

17 August 2016

serotonin receptor agonists

1 reference

5 March 2018

vasoconstrictor agents

1 reference

Medical Subject Headings

MeSH descriptor ID

D018170

serotonin 5-HT1 receptor agonist

15 March 2018

1 reference

Institute for Safe Medication Practices

Medical Subject Headings

15 March 2018

SUMAtriptan

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

2 September 2022

0 references

0 references

Sumatriptan

0 references

Identifiers

InChI

InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3

1 reference

sumatriptan (English)

KQKPFRSPSRPDEB-UHFFFAOYSA-N

19 November 2016

InChIKey

2 references

sumatriptan (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

103628-46-2

2 references

sumatriptan (English)

KQKPFRSPSRPDEB-UHFFFAOYSA-N

19 November 2016

InChIKey

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=103628-46-2

1 reference

Sumatriptan (English)

19 November 2016

1 reference

sumatriptan (English)

19 November 2016

Reaxys registry number

5346011

1 reference

sumatriptan (English)

3 October 2016

ChEBI ID

10650

mapping relation type

1 reference

SUMATRIPTAN (English)

19 November 2016

1 reference

splash10-0a4i-9400000000-93cc7dc7e521f98aa292

SUMATRIPTAN (English)

19 November 2016

1 reference

0 references

HSDB ID

7742

1 reference

Hazardous Substances Data Bank

28 October 2019

Sumatriptan (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

DTXCID303628

0 references

EC number

600-462-9

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.130.518

27 December 2018

ECHA Substance Infocard ID

1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide (English)

quotation

CAS no.: 103628-46-2 (English)

100.130.518

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.130.518

27 December 2018

1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide (English)

quotation

CAS no.: 103628-46-2 (English)

1 reference

Sumatriptan (English)

publication date

17 November 2015

1 reference

sumatriptan (English)

19 November 2016

Sumatriptan

0 references

0 references

0 references

0 references

D03.633.100.473.914.907

0 references

RxNorm ID

37418

1 reference

sumatriptan (English)

19 November 2016

1 reference

Sumatriptan (English)

Human Metabolome Database ID

19 November 2016

HMDB0005037

1 reference

based on heuristic

inferred from InChIKey

1 reference

sumatriptan (English)

MedlinePlus drug identifier

19 November 2016

a601116

oral administration

0 references

a696023

subcutaneous injection

0 references

a614029

PatientsLikeMe treatment ID

nasal administration

0 references

0 references

1 reference

sumatriptan (English)

19 November 2016

0 references

1 reference

1 reference

sumatriptan (English)

3 October 2016

1 reference

sumatriptan (English)

electronic Essential Medicines List medicine ID

3 October 2016

DeCS ID

31024

0 references

0 references

1 reference

28 October 2013

History of Modern Biomedicine ID

0 references

1 reference

9 July 2020

Microsoft Academic ID

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI

C0075632

1 reference